2013 Q1 Form 10-Q Financial Statement

#000119312513146087 Filed on April 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1 2011 Q4
Revenue $619.5M $611.3M $565.7M
YoY Change 1.35% 7.34% -2.59%
Cost Of Revenue $522.5M $527.9M $509.0M
YoY Change -1.03% 9.71% -0.36%
Gross Profit $97.03M $83.33M $56.61M
YoY Change 16.43% -5.58% -18.92%
Gross Profit Margin 15.66% 13.63% 10.01%
Selling, General & Admin $63.22M $62.49M $52.90M
YoY Change 1.17% 4.5% -7.19%
% of Gross Profit 65.16% 74.99% 93.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.05M $14.65M $13.12M
YoY Change 16.34% -7.26% -16.44%
% of Gross Profit 17.57% 17.58% 23.18%
Operating Expenses $63.22M $62.49M $52.90M
YoY Change 1.17% 4.67% -7.19%
Operating Profit $33.41M $18.08M $2.849M
YoY Change 84.82% -36.7% -77.78%
Interest Expense $6.158M $5.073M $4.756M
YoY Change 21.39% -59.09% -58.28%
% of Operating Profit 18.43% 28.07% 166.94%
Other Income/Expense, Net -$500.0K $700.0K $300.0K
YoY Change -171.43% -450.0% -400.0%
Pretax Income $53.56M $37.74M $20.28M
YoY Change 41.94% -6.13% -16.18%
Income Tax $16.23M $9.337M $6.083M
% Of Pretax Income 30.3% 24.74% 29.99%
Net Earnings $37.13M $25.88M $11.99M
YoY Change 43.47% -1.69% -17.17%
Net Earnings / Revenue 5.99% 4.23% 2.12%
Basic Earnings Per Share $0.53 $0.38 $0.17
Diluted Earnings Per Share $0.52 $0.37 $0.17
COMMON SHARES
Basic Shares Outstanding 69.79M shares 68.97M shares 69.35M shares
Diluted Shares Outstanding 71.91M shares 69.51M shares 69.36M shares

Balance Sheet

Concept 2013 Q1 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.40M $35.30M $53.80M
YoY Change 5.95% -28.97% -11.66%
Cash & Equivalents $37.36M $35.27M $53.81M
Short-Term Investments
Other Short-Term Assets $62.30M $80.50M $78.00M
YoY Change -22.61% 35.75% 42.34%
Inventory $373.4M $395.1M $335.1M
Prepaid Expenses
Receivables $375.5M $373.5M $328.6M
Other Receivables $15.10M $4.300M $13.20M
Total Short-Term Assets $863.6M $888.6M $808.7M
YoY Change -2.82% 6.23% 3.99%
LONG-TERM ASSETS
Property, Plant & Equipment $454.6M $455.1M $399.0M
YoY Change -0.1% -8.17% -18.2%
Goodwill $179.7M
YoY Change
Intangibles $112.2M
YoY Change
Long-Term Investments $256.3M $238.0M $233.2M
YoY Change 7.67% 90.25% 90.83%
Other Assets $18.86M $23.20M $23.20M
YoY Change -18.73% 39.76% 58.9%
Total Long-Term Assets $1.022B $970.8M $800.9M
YoY Change 5.23% 28.33% 9.03%
TOTAL ASSETS
Total Short-Term Assets $863.6M $888.6M $808.7M
Total Long-Term Assets $1.022B $970.8M $800.9M
Total Assets $1.885B $1.859B $1.610B
YoY Change 1.39% 16.72% 6.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $245.9M $264.3M $177.2M
YoY Change -6.98% -0.56% -10.01%
Accrued Expenses $36.76M $97.80M $77.20M
YoY Change -62.41% 1.66% -15.72%
Deferred Revenue
YoY Change
Short-Term Debt $30.59M $285.8M $226.1M
YoY Change -89.3% 253.71% 82.78%
Long-Term Debt Due $1.111M $600.0K
YoY Change 85.17%
Total Short-Term Liabilities $380.7M $657.0M $489.4M
YoY Change -42.05% 45.94% 16.63%
LONG-TERM LIABILITIES
Long-Term Debt $406.5M $252.5M $250.3M
YoY Change 61.0% 0.88% 0.04%
Other Long-Term Liabilities $72.56M $122.9M $71.50M
YoY Change -40.96% 75.82% -2.19%
Total Long-Term Liabilities $479.1M $375.4M $321.8M
YoY Change 27.62% 17.24% -0.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $380.7M $657.0M $489.4M
Total Long-Term Liabilities $479.1M $375.4M $321.8M
Total Liabilities $1.024B $1.169B $946.1M
YoY Change -12.33% 30.15% 11.86%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $816.9M $690.8M $663.6M
YoY Change
Total Liabilities & Shareholders Equity $1.885B $1.859B $1.610B
YoY Change 1.39% 16.72% 6.43%

Cashflow Statement

Concept 2013 Q1 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income $37.13M $25.88M $11.99M
YoY Change 43.47% -1.69% -17.17%
Depreciation, Depletion And Amortization $17.05M $14.65M $13.12M
YoY Change 16.34% -7.26% -16.44%
Cash From Operating Activities $36.30M $87.44M $64.36M
YoY Change -58.48% 34.52% 8.16%
INVESTING ACTIVITIES
Capital Expenditures $9.786M $5.769M $3.559M
YoY Change 69.63% -213.12% -179.09%
Acquisitions $152.4M $38.78M
YoY Change
Other Investing Activities $500.0K -$105.2M -$32.50M
YoY Change -100.48% 445.08% -855.81%
Cash From Investing Activities -$9.234M -$111.0M -$36.04M
YoY Change -91.68% 354.74% 35935.0%
FINANCING ACTIVITIES
Cash Dividend Paid $27.04M $8.273M $8.414M
YoY Change 226.85%
Common Stock Issuance & Retirement, Net $17.33M $1.186M $16.40M
YoY Change 1361.38%
Debt Paid & Issued, Net $365.0K $95.00K
YoY Change 284.21%
Cash From Financing Activities -22.60M 4.979M -11.39M
YoY Change -553.91% -109.61% -82.01%
NET CHANGE
Cash From Operating Activities 36.30M 87.44M 64.36M
Cash From Investing Activities -9.234M -111.0M -36.04M
Cash From Financing Activities -22.60M 4.979M -11.39M
Net Change In Cash 4.470M -18.54M 16.93M
YoY Change -124.11% 65.54% -534.13%
FREE CASH FLOW
Cash From Operating Activities $36.30M $87.44M $64.36M
Capital Expenditures $9.786M $5.769M $3.559M
Free Cash Flow $26.52M $81.67M $60.80M
YoY Change -67.53% 16.5% -5.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53806000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32889000
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69014000 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35266000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37962000
CY2013Q1 us-gaap Goodwill
Goodwill
179662000
CY2013Q1 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
3040000
CY2013Q1 us-gaap Equity Method Investments
EquityMethodInvestments
256262000
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
407634000
CY2013Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
1066000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
20176000
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
8516000
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
4584000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18855000
CY2013Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
8516000
CY2013Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
30588000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
816875000
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
860795000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
183464000
CY2013Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2725000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62986000
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70168000 shares
CY2013Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
102782000
CY2013Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
376534000
CY2013Q1 us-gaap Liabilities
Liabilities
1024387000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
245862000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
72562000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
662079000
CY2013Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
15127000
CY2013Q1 us-gaap Assets
Assets
1885182000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
1017686000
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
100465000
CY2013Q1 us-gaap Inventory Net
InventoryNet
373382000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1885182000
CY2013Q1 us-gaap Minority Interest
MinorityInterest
43920000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37359000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
531497000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
355607000
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
112183000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36763000
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
184033000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
1017686000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
380709000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3978000
CY2013Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
429528000
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1066000
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23141000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
863580000
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
86567000
CY2013Q1 us-gaap Long Lived Assets Held For Sale Gain Loss On Sale
LongLivedAssetsHeldForSaleGainLossOnSale
1886000
CY2013Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
674000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
454640000
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1111000
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
406523000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Long Term Debt
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebt
273870000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Long Term Debt Current Maturities
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebtCurrentMaturities
5394000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Other Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherNoncurrentLiabilities
23461000
CY2013Q1 wor Distributions In Excess Of Investment In Unconsolidated Affiliates
DistributionsInExcessOfInvestmentInUnconsolidatedAffiliates
64128000
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71101578 shares
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56167000
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41402000
CY2012Q2 us-gaap Goodwill
Goodwill
156681000
CY2012Q2 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
7202000
CY2012Q2 us-gaap Equity Method Investments
EquityMethodInvestments
240882000
CY2012Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
258791000
CY2012Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
1157000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
20906000
CY2012Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
14993000
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
5583000
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22585000
CY2012Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
14993000
CY2012Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
274923000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
697174000
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
747437000
CY2012Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
174016000
CY2012Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
11697000
CY2012Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71271000
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
115510000
CY2012Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
400869000
CY2012Q2 us-gaap Liabilities
Liabilities
1130360000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
252334000
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
72371000
CY2012Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
626975000
CY2012Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
892000
CY2012Q2 us-gaap Assets
Assets
1877797000
CY2012Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
972475000
CY2012Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
73099000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38231000
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
211543000
CY2012Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
972475000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
658263000
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3329000
CY2012Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
274754000
CY2012Q2 us-gaap Inventory Net
InventoryNet
401940000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1877797000
CY2012Q2 us-gaap Minority Interest
MinorityInterest
50263000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41028000
CY2012Q2 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
481912000
CY2012Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
345500000
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
100333000
CY2012Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1157000
CY2012Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16103000
CY2012Q2 us-gaap Assets Current
AssetsCurrent
914239000
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
74887000
CY2012Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
8478000
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
443077000
CY2012Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1329000
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
257462000
CY2012Q2 wor Equity Method Investment Summarized Financial Information Long Term Debt
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebt
289308000
CY2012Q2 wor Equity Method Investment Summarized Financial Information Long Term Debt Current Maturities
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebtCurrentMaturities
5305000
CY2012Q2 wor Equity Method Investment Summarized Financial Information Other Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherNoncurrentLiabilities
21934000
CY2012Q2 wor Distributions In Excess Of Investment In Unconsolidated Affiliates
DistributionsInExcessOfInvestmentInUnconsolidatedAffiliates
69165000
dei Trading Symbol
TradingSymbol
WOR
dei Entity Registrant Name
EntityRegistrantName
WORTHINGTON INDUSTRIES INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-02-28
dei Entity Central Index Key
EntityCentralIndexKey
0000108516
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
19256000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3412000
us-gaap Operating Income Loss
OperatingIncomeLoss
95646000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1899000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
962000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
8603000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32960000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-911000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
62110000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1170000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12941000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
110271000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2239000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-107000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1520000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48136000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
1306758000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
1203000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34871000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
575000
us-gaap Profit Loss
ProfitLoss
104818000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-1008000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.52
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1493000
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-163000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
16227000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
195683000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80285000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
1908184000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
9207000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-2608000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32960000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34402000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-251586000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3669000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
150000000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3135000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
201000
us-gaap Restructuring Charges
RestructuringCharges
1811000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1634000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70501000 shares
us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Economic (Non-designated) Hedges</b></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px" align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">We enter into foreign currency contracts to manage our foreign exchange exposure related to inter-company and financing transactions that do not meet the requirements for hedge accounting treatment. We also enter into certain commodity contracts that do not qualify for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings.</font></p> </div>
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1064000
us-gaap Sales Revenue Net
SalesRevenueNet
1908184000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6400000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7692000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.49
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-119067000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
54324000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
222000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
6400000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
2501000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
8582000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3455000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68998000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-42743000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
73580000
us-gaap Payments For Restructuring
PaymentsForRestructuring
3345000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-97000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1622651000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
298000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
8582000
us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash Flow Hedges</b></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px" align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (&#x201C;OCI&#x201D;) and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. The ineffective portion of the gain or loss on the derivative instrument is recognized in earnings immediately.</font></p> </div>
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10586000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
152539000
us-gaap Gross Profit
GrossProfit
285533000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
158570000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9850000
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
254796000
us-gaap Dividends Cash
DividendsCash
36471000
us-gaap Net Income Loss
NetIncomeLoss
102919000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3455000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187744000
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
2509000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-27078000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47721000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
112510000
us-gaap Payments Of Dividends
PaymentsOfDividends
44144000
us-gaap Interest Expense
InterestExpense
17751000
wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
29089000
wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
6681000
wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
169997000
wor Estimated Annual Effective Tax Rate
EstimatedAnnualEffectiveTaxRate
0.318 pure
wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
5488000
wor Joint Venture Transactions
JointVentureTransactions
-1188000
wor Joint Venture Transaction Costs
JointVentureTransactionCosts
1188000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9709000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
232171000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
95000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
59600000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5805000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-43238000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-2408000
wor Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred Tax
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferredTax
700000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-1711000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
86000
us-gaap Operating Income Loss
OperatingIncomeLoss
42107000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7422000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40626000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
1258185000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.90
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-56871000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
205000
us-gaap Profit Loss
ProfitLoss
70939000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-713000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
52120000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
14525000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
136953000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190208000
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
1779294000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
766000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1047000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15800000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
108460000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-20901000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1794000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
382000
us-gaap Restructuring Charges
RestructuringCharges
4707000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13126000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70481000 shares
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1408000
us-gaap Sales Revenue Net
SalesRevenueNet
1779294000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4439000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5534000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32354000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
1925000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
9744000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69952000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-23726000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
70614000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1567894000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8576000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
99612000
us-gaap Gross Profit
GrossProfit
211400000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
151779000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7511000
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
246714000
us-gaap Net Income Loss
NetIncomeLoss
63517000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160751000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-27449000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28673000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65405000
us-gaap Payments Of Dividends
PaymentsOfDividends
23856000
us-gaap Interest Expense
InterestExpense
14517000
wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
25164000
wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
3751000
wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
166257000
wor Estimated Annual Effective Tax Rate
EstimatedAnnualEffectiveTaxRate
0.319 pure
wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
12032000
wor Joint Venture Transactions
JointVentureTransactions
3835000
CY2013Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
4841000
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1434000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33406000
CY2013Q1 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000
CY2013Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-994000
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17332000
CY2013Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
128000
CY2013Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
365000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36283000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
182000
CY2013Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-76000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17048000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
421645000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
35320000
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
76000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
37331000
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
113000
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9576000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69509000 shares
CY2012Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
728000
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
611255000
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6933000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4470000
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
837000
CY2013Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
552000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36304000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9234000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
CY2013Q1 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
619527000
CY2013Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
4753000
CY2013Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-800000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9786000
CY2013Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-13390000
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-198000
CY2013Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
28000
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
146000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71914000 shares
CY2013Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
596000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
619527000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1675000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-866000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22600000
CY2013Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
153000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1675000
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
724000
CY2013Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
2592000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3455000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69791000 shares
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15158000
CY2013Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25716000
CY2013Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-15000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
522501000
CY2013Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
43000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3653000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53560000
CY2013Q1 us-gaap Gross Profit
GrossProfit
97026000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
57421000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6491000
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
90570000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
37131000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3455000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63221000
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
41672000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16229000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36465000
CY2013Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
27040000
CY2013Q1 us-gaap Interest Expense
InterestExpense
6158000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
9979000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
2212000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
61387000
CY2013Q1 wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
1842000
CY2013Q1 wor Joint Venture Transactions
JointVentureTransactions
253000
CY2012Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-3998000
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1296000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18075000
CY2012Q1 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
CY2012Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2518000
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1186000
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
152389000
CY2012Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
95000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31825000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3242000
CY2012Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-44023000
CY2012Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-112000
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14653000
CY2012Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
409981000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90258000
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
316000
CY2012Q1 us-gaap Profit Loss
ProfitLoss
28398000
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2012Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
167000
CY2012Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3178000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87438000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110957000
CY2012Q1 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
611255000
CY2012Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1899000
CY2012Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-784000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5769000
CY2012Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
15329000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18540000
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1046000
CY2012Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
431000
CY2012Q1 us-gaap Restructuring Charges
RestructuringCharges
956000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2797000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37735000
CY2012Q1 us-gaap Gross Profit
GrossProfit
83332000
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6669000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4979000
CY2012Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-143000
CY2012Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
3168000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68972000 shares
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31049000
CY2012Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24005000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
527923000
CY2012Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
51955000
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-667000
CY2012Q1 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
82904000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
25880000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62489000
CY2012Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
28643000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9337000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
35067000
CY2012Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
8273000
CY2012Q1 us-gaap Interest Expense
InterestExpense
5073000
CY2012Q1 wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
8431000
CY2012Q1 wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
1925000
CY2012Q1 wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
56219000
CY2012Q1 wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
1908000
CY2012Q1 wor Joint Venture Transactions
JointVentureTransactions
1812000

Files In Submission

Name View Source Status
0001193125-13-146087-index-headers.html Edgar Link pending
0001193125-13-146087-index.html Edgar Link pending
0001193125-13-146087.txt Edgar Link pending
0001193125-13-146087-xbrl.zip Edgar Link pending
d497266d10q.htm Edgar Link pending
d497266dex101.htm Edgar Link pending
d497266dex311.htm Edgar Link pending
d497266dex312.htm Edgar Link pending
d497266dex321.htm Edgar Link pending
d497266dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g497266g19b95.jpg Edgar Link pending
g497266g44z89.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wor-20130228.xml Edgar Link completed
wor-20130228.xsd Edgar Link pending
wor-20130228_cal.xml Edgar Link unprocessable
wor-20130228_def.xml Edgar Link unprocessable
wor-20130228_lab.xml Edgar Link unprocessable
wor-20130228_pre.xml Edgar Link unprocessable